Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings

Journal of Nuclear Medicine

Volumn 37, Issue 12, 1996, Pages 2000-2001

  Neumann, Donald R ^a   Esselstyn, Caldwell B ^a   Kim, Eunice Y ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Fluorine 18 fluorodeoxyglucose; Hyperparathyroidism; Parathyroid carcinoma; Technetium 99m sestamibi

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; FOLLOW UP; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMAGE ANALYSIS; LETHARGY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID CARCINOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK;

AGED; CARCINOMA; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; HYPERPARATHYROIDISM; MALE; NEOPLASM RECURRENCE, LOCAL; PARATHYROID NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030470307     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sandelin K, Auer G, Bondeson I, Gremelius I, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World, J Surg 1922;16;724-731.
2. Daly BD, Coffey SL, Behan M. Case reports: ultrasonographic appearance of parathyroid carcinoma. Br J Radiol 1989;62:1017-1019.
3. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg 1991;15:738-744.
4. Spritzer CE, Gefter WB, Hamilton R, Greenburg BM, Axel L, Kressel HY. Abnormal parathyroid glands: high resolution MR imaging. Radiology 1987;162:487-491.
5. Kitapci MT, Tastekin G, Turgut M, et al. Preoperative localization of parathyroid carcinoma using technetium-99m-MIBI. Clin Nucl Med 1993;18:217-219.
6. Beirwalters W. Endocrine imaging: parathyroid, adrenal cortex and medulla, and other endocrine tumors. Part 2. J Nucl Med 1991;32:1627-1639.
7. Iwase M, Shimizu Y, Kitahara H, Tobioka N, Takatsuki K.. Parathyroid carcinoma visualized by gallium-67-citrate scintigraphy. J Nucl Med 1986;27:63-65.
8. Stavraka-Katavaki A, Fronistas O, Toumbouros M, Manolas C. Parathyroid carcinoma: report of three cases. Clin Nucl Med 1992;17:1-3.
9. Rademaker P, Meijer S, Oosterhuis JW, et al. Successful surgical treatment of parathyroid carcinoma in two hemodialysis patients. Nephrol Dial Transplant 1990; 5:545-548.
10. Nazem A, Anderson B, Leffall LD, Reghini M, Brown J. Parathyroid adenocarcinoma. JAMA 1987;81:785-789.
11. Klink BK, Karulf RE, Maimon WN, Peoples JB. Nonfunctioning parathyroid carcinoma. Am Surg 1991;57:463-467.
12. Schantz A, Castleman B. Parathyroid carcinoma: a study of 70 cases. Cancer 1973;31:600-605.
13. 18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-371.
14. Okada J, Yoshikawa K, Itami M, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. J Nucl Med 1992;33:325-329.
15. 18F] 2-deoxy-2-fluoro-D-glucose PET. Radiology 1993; 187:743-750.
16. Neumann DR, Esselstyn CB, Siciliano D. Preoperative imaging of parathyroid carcinoma by positron emission tomography. Ann Otol Rhin Laryngol 1994;103:741-745.
17. Coakley AJ, Kettle AG, Wells CP, et al. Technetium-99m-sestamibi: a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-794.
18. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33: 1801-1807.